PEMAC Assets is a CMMS and EAM platform developed by PEMAC, an Irish software company with primary market presence in Ireland, the UK, and Europe. The platform targets asset-intensive manufacturing, pharmaceutical, food and beverage, and utilities organizations that require robust compliance documentation, safety work permit management, and comprehensive preventive maintenance capability.
PEMAC is a market leader in Ireland for manufacturing CMMS and has built a customer base across European regulated industries, particularly in pharmaceutical and food manufacturing where GMP and quality standards create demanding maintenance documentation requirements.PEMAC Assets covers the full CMMS feature set required by complex manufacturers: asset hierarchies with equipment records and document management
PM scheduling and management, corrective work order management, parts and inventory management, procurement, calibration management, safety work permits, and maintenance KPI reporting.
The platform has invested specifically in regulatory compliance features, electronic batch record integration , 21 CFR Part 11 compliant electronic signatures, audit trail management, that serve pharmaceutical and food manufacturers under FDA and HPRA (Irish Health Products Regulatory Authority) oversight.PEMAC Assets is best suited for: Irish and UK manufacturers seeking a CMMS vendor with local presence and support
pharmaceutical manufacturers under FDA 21 CFR Part 11 or EMA GMP requirements who need validated system deployment support food manufacturers under FSAI or HACCP compliance requirements and mid-to-large manufacturers with complex PM programs and safety-critical equipment that require enterprise CMMS depth with European vendor proximity.
21 CFR Part 11 compliance capability is a genuine PEMAC differentiator for pharmaceutical manufacturers.
Electronic records maintained in PEMAC Assets can be configured to meet Part 11 requirements for audit trails, access controls, and electronic signatures, and PEMAC provides an IQ/OQ validation package that supports the formal computer system validation (CSV) process required for FDA-regulated manufacturing environments.
This validation infrastructure significantly reduces the validation burden for pharmaceutical manufacturers compared to CMMS platforms that require customers to build validation documentation from scratch.GMP maintenance documentation requirements, maintenance procedures linked to equipment records, change control for PM interval modifications, controlled document version management, are well-supported in PEMAC Assets.
The ability to attach controlled maintenance procedures directly to work order templates ensures that technicians executing preventive maintenance reference the current approved procedure version, supporting GMP compliance requirements for procedure-based work execution.HACCP and food safety compliance support for food manufacturers includes hygiene-focused maintenance workflow features, distinguishing between maintenance activities that require pre-cleaning validation, identifying food contact vs.
non-food contact maintenance zones, and supporting the maintenance-side documentation requirements of BRC and SQF audits.
Food manufacturers operating PEMAC Assets can produce maintenance compliance evidence for food safety audits from the CMMS rather than maintaining separate compliance records, reducing the documentation duplication burden that manually-managed compliance programs create.
PEMAC's geographic concentration in Ireland and the UK creates considerations for manufacturers in North America, continental Europe, or other regions evaluating the platform.
Local implementation support, time zone-aligned customer service, and reference customers in the same geography and industry are standard evaluation criteria that are easier to satisfy for Irish and UK manufacturers than for those in other regions.
PEMAC has expanded into continental Europe and has some North American customers, but the vendor's support infrastructure and reference customer base are most dense in Ireland and the UK.PEMAC Assets' pricing is competitive for enterprise CMMS within its market, but total implementation cost, including validation services for pharmaceutical customers, can be significant.
The validation investment is justified for pharmaceutical manufacturers who require it, but represents a cost component that non-regulated manufacturers should factor into their total cost of ownership comparison versus CMMS alternatives that do not require formal CSV validation.For manufacturers outside PEMAC's core pharmaceutical and food sectors evaluating the platform, the regulatory compliance features are present but may represent over-engineering for organizations without formal compliance requirements.
General discrete manufacturers, automotive, electronics, machinery, would find PEMAC Assets capable but would be paying for compliance functionality they do not need.
These manufacturers are likely better served by CMMS platforms whose development investment is more focused on production-integrated maintenance and OEE connectivity rather than regulatory documentation management.
Login
Blog
